KR880001715B1 - 1-푸릴-3,4-디하이드로이소퀴놀린의 제조방법 - Google Patents

1-푸릴-3,4-디하이드로이소퀴놀린의 제조방법 Download PDF

Info

Publication number
KR880001715B1
KR880001715B1 KR8204977A KR820004977A KR880001715B1 KR 880001715 B1 KR880001715 B1 KR 880001715B1 KR 8204977 A KR8204977 A KR 8204977A KR 820004977 A KR820004977 A KR 820004977A KR 880001715 B1 KR880001715 B1 KR 880001715B1
Authority
KR
South Korea
Prior art keywords
acid
group
furan
formula
furyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
KR8204977A
Other languages
English (en)
Korean (ko)
Other versions
KR840002375A (ko
Inventor
뢰젤 왈터
루스 오토
라이클 리카르트
쿤 프란쯔-조세프
Original Assignee
페터 베어호프, 기젤라 벨만
베링거 잉겔하임 케이지
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 페터 베어호프, 기젤라 벨만, 베링거 잉겔하임 케이지 filed Critical 페터 베어호프, 기젤라 벨만
Publication of KR840002375A publication Critical patent/KR840002375A/ko
Application granted granted Critical
Publication of KR880001715B1 publication Critical patent/KR880001715B1/ko
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines Containing Plant Substances (AREA)
KR8204977A 1981-11-05 1982-11-04 1-푸릴-3,4-디하이드로이소퀴놀린의 제조방법 Expired KR880001715B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP3143876.8 1981-11-05
DE19813143876 DE3143876A1 (de) 1981-11-05 1981-11-05 Neue1-furyl-3,4-dihydroisochinoline diese enthaltende arzneimittel sowie verfahren zu deren herstellung und deren verwendung

Publications (2)

Publication Number Publication Date
KR840002375A KR840002375A (ko) 1984-06-25
KR880001715B1 true KR880001715B1 (ko) 1988-09-08

Family

ID=6145648

Family Applications (1)

Application Number Title Priority Date Filing Date
KR8204977A Expired KR880001715B1 (ko) 1981-11-05 1982-11-04 1-푸릴-3,4-디하이드로이소퀴놀린의 제조방법

Country Status (26)

Country Link
US (1) US4452789A (https=)
EP (1) EP0078949B1 (https=)
JP (1) JPS5885883A (https=)
KR (1) KR880001715B1 (https=)
AT (1) ATE13887T1 (https=)
AU (1) AU557772B2 (https=)
CA (1) CA1190545A (https=)
CS (1) CS228942B2 (https=)
DD (1) DD208616A5 (https=)
DE (2) DE3143876A1 (https=)
DK (1) DK490282A (https=)
ES (1) ES8401062A1 (https=)
FI (1) FI74960C (https=)
GB (1) GB2110671B (https=)
GR (1) GR77057B (https=)
HU (1) HU190995B (https=)
IE (1) IE54085B1 (https=)
IL (1) IL67168A0 (https=)
NO (1) NO158676C (https=)
NZ (1) NZ202391A (https=)
PH (1) PH18875A (https=)
PL (1) PL134673B1 (https=)
PT (1) PT75793B (https=)
SU (1) SU1149877A3 (https=)
YU (1) YU42057B (https=)
ZA (1) ZA828068B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3603194A1 (de) * 1986-02-03 1987-08-06 Boehringer Ingelheim Kg Neue 2-amino-3-formyl-furane, verfahren zu ihrer herstellung und die enthaltenden pharmazeutischen zusammensetzungen
KR100544521B1 (ko) * 2001-11-15 2006-01-23 박주섭 무우 써는 기계
US6973298B2 (en) * 2003-03-27 2005-12-06 Kyocera Wireless Corp. Location capable mobile handset
CN102762571A (zh) 2009-12-23 2012-10-31 拜奥克里斯特制药公司 作为janus激酶抑制剂的杂环化合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1620496A1 (de) * 1965-03-24 1970-01-02 Thomae Gmbh Dr K Verfahren zur Herstellung von neuen 1-Pyridyl-3,4-dihydroisochinolinen
FR2351656A1 (fr) * 1976-05-21 1977-12-16 Rhone Poulenc Ind Nouveaux derives de la dibenzo(de, h) quinoleine, leur preparation et les compositions qui les contiennent
US4190660A (en) * 1978-08-11 1980-02-26 Siu Patrick M Anti-drug withdrawal syndrome composition and method of use
DE3013906A1 (de) * 1980-04-11 1981-10-15 C.H. Boehringer Sohn, 6507 Ingelheim Substituierte (alpha) -aminocarbonyl-l-benzyl-3,4-dihydro-isochinoline, verfahren zu deren herstellung und deren verwendung

Also Published As

Publication number Publication date
CS228942B2 (en) 1984-05-14
JPS5885883A (ja) 1983-05-23
GB2110671A (en) 1983-06-22
FI74960C (fi) 1988-04-11
IE54085B1 (en) 1989-06-07
ATE13887T1 (de) 1985-07-15
YU246482A (en) 1984-12-31
DD208616A5 (de) 1984-04-04
EP0078949A1 (de) 1983-05-18
IL67168A0 (en) 1983-03-31
ES517108A0 (es) 1983-11-16
DE3143876A1 (de) 1983-05-11
SU1149877A3 (ru) 1985-04-07
PT75793A (de) 1982-12-01
NO158676B (no) 1988-07-11
GR77057B (https=) 1984-09-05
IE822637L (en) 1983-05-05
PH18875A (en) 1985-10-21
NO158676C (no) 1988-10-19
EP0078949B1 (de) 1985-06-19
US4452789A (en) 1984-06-05
AU9021882A (en) 1983-05-12
ZA828068B (en) 1984-07-25
ES8401062A1 (es) 1983-11-16
FI74960B (fi) 1987-12-31
FI823732L (fi) 1983-05-06
PL238869A1 (en) 1984-03-12
FI823732A0 (fi) 1982-11-02
NO823676L (no) 1983-05-06
HU190995B (en) 1986-12-28
DK490282A (da) 1983-05-06
PL134673B1 (en) 1985-09-30
CA1190545A (en) 1985-07-16
PT75793B (de) 1986-01-21
NZ202391A (en) 1985-01-31
DE3264303D1 (en) 1985-07-25
AU557772B2 (en) 1987-01-08
KR840002375A (ko) 1984-06-25
YU42057B (en) 1988-04-30
GB2110671B (en) 1985-04-17

Similar Documents

Publication Publication Date Title
KR101221864B1 (ko) 4-［［(7ｒ)-8-사이클로펜틸-7-에틸-5,6,7,8-테트라하이드로-5-메틸-6-옥소-2-프테리디닐］아미노］-3-메톡시-ｎ-(1-메틸-4-피페리디닐)벤즈아미드의 수화물 및 다형체, 이들의 제조방법, 및 약제로서의 이들의 용도
EP0630894A1 (en) Propenoic acid derivatives as adenosine A1 antagonists
US5354760A (en) Crystalline Tiagabine monohydrate, its preparation and use
JPH0428269B2 (https=)
KR880001715B1 (ko) 1-푸릴-3,4-디하이드로이소퀴놀린의 제조방법
KR920005827B1 (ko) 벤조티아디아제핀 유도체
AT391316B (de) Neue thienyloxy-alkylamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP0270692A1 (en) Antiarrhythmic agent
US4703055A (en) Benzamides and therapeutic use thereof
JPH0764844B2 (ja) ピリダジノピロロイソキノリン誘導体
DE69223422T2 (de) Benzothiadiazinderivate
JPH0211592A (ja) 光学活性なジヒドロピリジンホスホン酸エステル
AU781283B2 (en) New crystalline polymorphic form of 1-methyl-5-p-toluoylpyrrole-2-acetamidoacetic acid guaiacyl ester (MED 15)
EP0424901A1 (en) Dihydropyridine derivatives and pharmaceutical compositions
JP2790335B2 (ja) 共役γ―オキシブテノライド化合物およびこれを有効成分とする抗潰瘍剤
CA1108629A (en) Maleic acid halfamides
JPH01113398A (ja) 光学活性なジヒドロピリジン−５−ホスホン酸エステル
KR850000431B1 (ko) 피롤 유도체의 제조방법
CN102796075B (zh) 苯并环庚烯类衍生物、其制备方法及医药用途
JPH11130772A (ja) 含窒素複素環化合物
KR20110081382A (ko) 결정성 아데포비어 디피복실 술폰산염 무수물, 그 제조방법 및 이를 포함하는 약제학적 조성물
KR20100125124A (ko) 피타바스타틴 헤미칼슘염의 신규한 결정형 및 그의 제조방법
JPH0576471B2 (https=)
JPS61152672A (ja) ジベンズ〔ｂ，ｅ〕オキセピン誘導体および抗アレルギ−剤
SI21067A2 (sl) Amlodipin hemimaleat

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1605 Publication of application before grant of patent

St.27 status event code: A-2-2-Q10-Q13-nap-PG1605

PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 19910909

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 19910909

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000